Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
Not reported
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits
Author:
Gordon, T., et al.
Year:
1992
Bibliographic source:
Am Ind Hyg Assoc J 53(8): 503-509

Materials and methods

Principles of method if other than guideline:
Fischer 344 rats were exposed to the test material for 3 h. After 0, 4 or 24 h observation time animals were anesthetized and cellular/biochemical changes occurring in bronchoalveolar lavage fluid were examined.
GLP compliance:
not specified
Test type:
other: Pulmonary study
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Zinc oxide
EC Number:
215-222-5
EC Name:
Zinc oxide
Cas Number:
1314-13-2
Molecular formula:
OZn
IUPAC Name:
(oxido)zinc
Details on test material:
- Name of test material (as cited in study report): zinc oxide

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories
- Weight at study initiation: 200-250 g
- Housing: hanging steel mesh cages
- Diet (e.g. ad libitum): standard laboratory animal chow (Purina Indianapolis Ind), ad libitum
- Water (e.g. ad libitum): sater, ad libitum

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose only
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Cannon 52 portchamber. LabProducts Inc., Maywood, NJ
- System of generating particulates/aerosols: Zinc granules were heated to approximately 550 °C in a crucible and the generated vapours were carried downstream by inert argon gas in the furnace to react with oxygen yielding zinc oxide vapours which was mixed with filtered air in a series of cooling/dilution heads before entering the exposure chamber.
- Method of particle size determination: Differential mobility analyzer (TSI Inc., St. Paul, Minn.)
- Temperature, humidity, pressure in air chamber: 25-30 °C and 30 %

TEST ATMOSPHERE
- Brief description of analytical method used: Monitored gravimetrically with teflon filters (Type FG 0.2 µm. Millipore, Bedford, Mass.) and Cahn balance (Model 21, Cahn InstrumentCerritos, Calif.) and filters were analyzed by atomic absorption spectroscopy periodically.

TEST ATMOSPHERE (if not tabulated)
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 0.17 µm
Analytical verification of test atmosphere concentrations:
yes
Remarks:
(Atomic absorption spectroscopy)
Duration of exposure:
3 h
Concentrations:
0, 2.5 and 5 mg/m³
No. of animals per sex per dose:
no data
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 0, 4 or 24 h
- Necropsy of survivors performed: Yes (animals were intraperitoneally anesthetized with Pentobarbital-390 mg/kg)
- Pulmonary lavage preparation: Tracheas were cannulated with sterile, blunt needles and lavaged twice with sterile, pyrogen-free, phosphate-buffered saline.
- Other examinations performed: Biochemical and cellular parameters like protein content, lactate dehydrogenase (LDH), β-glucuronidase level and cell counts were examined in bronchoalveolar lavage fluid.
Statistics:
Differences in lavage fluid parameters were analysed by one-way analysis of variance followed by a two-sided Dunnett's t-test.

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LC50
Effect level:
> 5 mg/m³ air
Exp. duration:
3 h
Sex:
male
Dose descriptor:
other: Increased level of total cell counts, protein content, LDH, and β-glucuronidase
Effect level:
2.5 mg/m³ air (nominal)
Exp. duration:
3 h
Mortality:
No mortality occured up to the end of the observation period.
Clinical signs:
other: Not applicable
Body weight:
Not applicable
Gross pathology:
Not applicable
Other findings:
- Other observations: Significant increases in protein content, lactate dehydrogenase (LDH), β-glucuronidase and cell counts were observed. The test material caused dose-dependent acute inflammation of lungs in rats under the conditions of this test.

Any other information on results incl. tables

LC50 values were not calculated within the publication. However, as no mortality was reported up to the end of the observation period, a LC50 > 5mg/m³ is considered.

Cellular and biochemical changes occurring in bronchoalveolar lavage fluid were examined. Significant increases in protein content, LDH, β-glucuronidase and cell counts were observed.

Table1: Retention of ultrafine test material particles

Exposure Conc.(mg/m3) Exposure duration (h) Minute volumeA (L) Total Zn InhaledB(µg) Baseline Zn levelC, D(µg Zn/g tissue) Zn Lung BurdenC(µg Zn/g tissue) Total Zn DepositedC, Eµg RetentionC, F(%)
4.3 3 0.1 77 22.0 ± 0.8 34.0 ± 0.9 9.0 ± 0.8 11.5 ± 1.0

Where

AMinute volume was calculated on the basis of the equation Y = aMbwhere Y is minute volume; M is mass in kg; and a and b are the coefficient and exponent, respectively, derived by Stahl

BTotal Zn inhaled = (exposure conc.) x (exposure duration) x (minute volume)

CValues are mean ± SE

DDerived from fumace gas-exposed animals.

ETotal Zn deposited = {(Zn lung burden) - (baseline Zn level)} x (wet lung weight)

F% retention = total Zn deposited / total Zn inhaled

Table 2: Exposure concentration

Target concentration  Actual concentration
 2.5 mg/m3  2.7 ± 0.1
 5.0 mg/m3  5.4±0.7

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria are not met, no classification required according to Regulations (EC) No 1272/2008